JP2011037847A5 - - Google Patents

Download PDF

Info

Publication number
JP2011037847A5
JP2011037847A5 JP2010173610A JP2010173610A JP2011037847A5 JP 2011037847 A5 JP2011037847 A5 JP 2011037847A5 JP 2010173610 A JP2010173610 A JP 2010173610A JP 2010173610 A JP2010173610 A JP 2010173610A JP 2011037847 A5 JP2011037847 A5 JP 2011037847A5
Authority
JP
Japan
Prior art keywords
galnac4st
c6st
test compound
gene
renal fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010173610A
Other languages
English (en)
Japanese (ja)
Other versions
JP4751956B2 (ja
JP2011037847A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010173610A priority Critical patent/JP4751956B2/ja
Priority claimed from JP2010173610A external-priority patent/JP4751956B2/ja
Publication of JP2011037847A publication Critical patent/JP2011037847A/ja
Publication of JP2011037847A5 publication Critical patent/JP2011037847A5/ja
Application granted granted Critical
Publication of JP4751956B2 publication Critical patent/JP4751956B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010173610A 2007-12-27 2010-08-02 糖鎖関連遺伝子、およびその利用 Active JP4751956B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010173610A JP4751956B2 (ja) 2007-12-27 2010-08-02 糖鎖関連遺伝子、およびその利用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007336518 2007-12-27
JP2007336518 2007-12-27
JP2010173610A JP4751956B2 (ja) 2007-12-27 2010-08-02 糖鎖関連遺伝子、およびその利用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009547912A Division JP4585611B2 (ja) 2007-12-27 2008-12-26 糖鎖関連遺伝子、およびその利用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011110047A Division JP5481426B2 (ja) 2007-12-27 2011-05-17 糖鎖関連遺伝子、およびその利用

Publications (3)

Publication Number Publication Date
JP2011037847A JP2011037847A (ja) 2011-02-24
JP2011037847A5 true JP2011037847A5 (enExample) 2011-05-26
JP4751956B2 JP4751956B2 (ja) 2011-08-17

Family

ID=40823968

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009547912A Active JP4585611B2 (ja) 2007-12-27 2008-12-26 糖鎖関連遺伝子、およびその利用
JP2010173610A Active JP4751956B2 (ja) 2007-12-27 2010-08-02 糖鎖関連遺伝子、およびその利用
JP2011110047A Active JP5481426B2 (ja) 2007-12-27 2011-05-17 糖鎖関連遺伝子、およびその利用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009547912A Active JP4585611B2 (ja) 2007-12-27 2008-12-26 糖鎖関連遺伝子、およびその利用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011110047A Active JP5481426B2 (ja) 2007-12-27 2011-05-17 糖鎖関連遺伝子、およびその利用

Country Status (7)

Country Link
US (6) US20110027248A1 (enExample)
EP (4) EP3360556B1 (enExample)
JP (3) JP4585611B2 (enExample)
KR (6) KR20100111282A (enExample)
CN (2) CN103656644A (enExample)
SG (2) SG10202001748VA (enExample)
WO (1) WO2009084232A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2685636T3 (es) * 2007-06-29 2018-10-10 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Método de fijación y expresión de sustancia fisiológicamente activa
CN102548393B (zh) * 2009-07-31 2015-06-03 斯特里克再生医学学院,斯特里克学院事务所 脂肪性肝炎-肝癌模型动物
IN2014MN00908A (enExample) 2011-11-18 2015-04-17 Nitto Denko Corp
US20150337313A1 (en) * 2012-07-17 2015-11-26 Stelic Institute & Co. Mucosal healing promoter
PL2992098T3 (pl) * 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
JP6302183B2 (ja) * 2013-07-12 2018-03-28 株式会社エンザミン研究所 アディポサイトカイン産生バランス調整剤及び脂肪組織の炎症・酸化ストレス抑制剤並びに脂肪組織のマクロファージ浸潤抑制剤
EP3265567B1 (en) 2015-03-02 2020-07-29 Conagen Inc. Regulatory elements from labyrinthulomycetes microorganisms
WO2017078054A1 (ja) 2015-11-04 2017-05-11 株式会社ステリック再生医科学研究所 ＲＮＡｉ分子とＮ－アセチル化キトサンとを含む複合体
US10633454B2 (en) 2016-11-01 2020-04-28 Conagen Inc. Expression of modified glycoproteins and glycopeptides
JP7129912B2 (ja) 2016-12-07 2022-09-02 株式会社ステリック再生医科学研究所 慢性疾患の治療及び予防用医薬組成物
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183934A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
WO2019173226A1 (en) * 2018-03-05 2019-09-12 Synthetic Genomics, Inc. Organisms and methods for producing glycomolecules with low sulfation
CN109897812B (zh) * 2019-03-19 2021-09-03 江南大学 一种表达软骨素4-硫酸转移酶基因的重组菌及其应用
CN113811313A (zh) * 2019-05-08 2021-12-17 Tme治疗医学有限公司 食管狭窄抑制剂
CN116254296A (zh) * 2023-03-27 2023-06-13 中国科学院微生物研究所 利用昆虫细胞杆状病毒表达系统表达硫酸软骨素修饰酶的方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4571242B2 (ja) * 1996-07-24 2010-10-27 生化学工業株式会社 ヒト由来のグリコサミノグリカンスルホトランスフェラーゼのポリペプチド及びそれをコードするｄｎａ
AU6897198A (en) * 1997-04-11 1998-11-11 Beth Israel Deaconess Medical Center Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
EP1839671A3 (en) * 1999-12-02 2007-10-31 BioMarin Pharmaceutical Inc. Attenuation of fibroblast proliferation
CA2393186A1 (en) * 1999-12-02 2001-06-07 Ibex Technologies, Inc. Attenuation of fibroblast proliferation
US6713274B2 (en) * 2002-05-13 2004-03-30 The Regents Of The University Of California Method for identifying modulators of sulfotransferase activity
EP1541580B1 (en) * 2002-07-10 2013-02-27 Seikagaku Corporation Sulfotransferase inhibitors
WO2005089316A2 (en) * 2004-03-12 2005-09-29 Intercept Pharmaceuticals, Inc. Treatment of fibrosis using fxr ligands
WO2007049361A1 (ja) * 2005-10-27 2007-05-03 Stelic Corp. 肝線維化抑制剤
WO2008020489A1 (en) 2006-08-17 2008-02-21 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Remedy for inflammatory bowel disease
JP4101276B2 (ja) 2006-08-25 2008-06-18 株式会社ステリック再生医科学研究所 慢性閉塞性肺疾患改善剤
JP2009286695A (ja) * 2006-09-08 2009-12-10 Stelic Institute Of Regenerative Medicine 眼線維性血管新生抑制剤
WO2008029493A1 (fr) * 2006-09-08 2008-03-13 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Inhibiteur de dégénération de fibres nerveuses
ES2685636T3 (es) 2007-06-29 2018-10-10 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Método de fijación y expresión de sustancia fisiológicamente activa

Similar Documents

Publication Publication Date Title
JP2011162558A5 (enExample)
JP2011168588A5 (enExample)
WO2008145400A3 (en) Mutated structural protein of a parvovirus
JP2011525793A5 (enExample)
Bagchi et al. The determinants of directionality in transcriptional initiation
JP2012065652A5 (enExample)
WO2012072096A8 (en) Method for cellular rna expression
BR112014015202A8 (pt) processo para a melhor separação de uma solução orgânica hidrófoba de um meio de cultura aquoso
WO2014070753A3 (en) Methods for processing clinical information
JP2013537035A5 (enExample)
JP2013544071A5 (enExample)
WO2012006148A3 (en) Genotype simulation estimates mis-classification rate in genotyping
SG161193A1 (en) System and method of utilizing resources within an information handling system
WO2012008839A3 (en) A method of analysing a blood sample of a subject for the presence of a disease marker
WO2010143871A3 (ko) 재설계 유전자 회로를 이용한 다양한 효소 활성의 탐색 및 정량 방법
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
JP2012518389A5 (enExample)
WO2013001372A3 (en) Methods and compositions for inhibition of activation of regulatory t cells
JP2014221834A5 (enExample)
BR112014005505A2 (pt) substrato de polinucleotídeo isolado para uma enzima de ácido nucleico catalítica, método para detectar a presença de pelo menos um alvo, uso do substrato de polinucleotídeo isolado e kit
WO2012142094A3 (en) Compositions and methods for increased ethanol production from biomass
WO2012037119A3 (en) Inhibitors of viral entry into mammalian cells
JP2013516982A5 (enExample)
Maslowsky Jr Inorganic metallocenes: the structures and aromaticity of sandwich compounds of the transition elements with inorganic rings
WO2012034130A3 (en) Methods and compositions for nucleic acid detection